Zimmer price target raised to $113 from $105 at Cantor Cantor increased its price target on Zimmer after the company agreed to buy Biomet. The firm thinks that, beginning in the second year of the deal, Zimmer's accretion guidance could be slightly conservative. It keeps a Buy rating on the stock.
JPMorgan to hold a conference 33rd Annual Healthcare Conference is being held in San Francisco on January 12-15 with webcasted company presentations to begin on January 13 at 10:30 am; not all company presentations may be webcasted. Webcast Link